NCT04042558
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04042558
Title A Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/-Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted Therapies (GFPC 06-2018)
Acronym GFPC 06-2018
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Centre Francois Baclesse
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
CHU Angers France Details
Centre Hospitalier Annecy France Details
CHU-Hôpital MORVAN Brest France Details
CHU Lyon Louis Pradel Bron France Details
Centre François Baclesse Caen 14076 France Details
CHU Gabriel MONTPIED Clermont-Ferrand France Details
CHIC Créteil France Details
CHU Grenoble France Details
CHU Réunion St Denis La Réunion France Details
CHU Réunion St Pierre La Réunion France Details
CHD Vendée La Roche sur Yon La Roche-sur-Yon France Details
CHU Lille France Details
CHU Limoges Limoges France Details
Centre Léon Bérard Lyon France Details
CHU Lyon, Croix-Rousse, Lyon France Details
Hôpital Nord Marseille France Details
CHR Orléans Orléans France Details
Hopital Foch Paris France Details
institut Curie Paris France Details
HIA Percy Percy France Details
Hôpital Haut Lévêque,Centre François Magendie Pessac France Details
CHU Pierre-Bénite France Details
CHU Rennes France Details
CHU Rouen France Details
ICLN, St Priez en Jarez Saint-Priest-en-Jarez France Details
Centre Paul Strauss Strasbourg France Details
HIA St Anne Toulon France Details
CHU Toulouse France Details
Centre Hospitalier Bretagne Atlantique Vannes France Details
Centre Hospitalier Villefranche France Details
HIA R.Picqué Villenave-d'Ornon France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field